Flatiron Health, a healthtech company, has acquired Protocol First, a software services provider concentrated on accelerating its clinical research.
Protocol First’s technology improves research efficiency by breaking down silos between sites, study sponsors and contract research organizations. The deal builds on Flatiron’s established presence in real-world evidence with new technologies that better integrate research into clinical care.
“Flatiron has deep expertise in unstructured-data processing, experience building software that integrates seamlessly into site workflows, and an engaged network of community and academic research sites,” said Alex Deyle, general manager, clinical research at Flatiron. “Protocol First’s technology expands and accelerates our ability to drive much-needed innovation in clinical research.”
“We are very excited about this combination, which will take our technology to the next level, scaling and broadening its availability across the life sciences industry,” said Hugh Levaux, who joins Flatiron as VP, clinical research.